US Medical Devices Ishares ETF (IHI)

Boston Scientific has significantly outperformed the broader market over the past year, and analysts maintain a very bullish view on its outlook.

Boston Scientific shows impressive growth in Q3 results, garnering bullish analyst support despite clinical trial setbacks.

Abbott is all set to release its third-quarter earnings later this month, and analysts expect a single-digit profit increase.

ETFs can be safe yet powerful investments. But there are still risks involved.

While Edwards Lifesciences has underperformed the broader medical devices industry recently, analysts are moderately bullish on the stock's prospects.

IDEXX Laboratories underperformed the broader healthcare sector, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

Medtronic has lagged behind other medical device stocks over the past months, yet Wall Street remains moderately bullish on the stock’s prospects.

Wall Street wrapped up August on a positive note after a turbulent start due to the tech sell-off. The Dow Jones touched a series of record highs, gaining 1.8%, while the S&P 500 marked its fourth straight...

STERIS has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s potential.

Although Teleflex has lagged behind the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.